California calls for unapproved Bexsero to stop its meningitis outbreak

California health officials have asked for permission to use Novartis' ($NVS) unapproved meningitis B vaccine Bexsero to control an outbreak at the University of California, Santa Barbara. Princeton University was allowed to import the vaccine to tackle a similar outbreak. New Jersey-based Princeton ran its vaccination campaign last week, with 91% of eligible students receiving the vaccine. Princeton will offer a booster shot in February. News | More

Suggested Articles

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

The partnership aims to make the production of vaccines that use adenovirus as vectors more cost-effective and contamination-free.

GSK's Shingrix has nabbed a huge chunk of the U.S. shingles-shot market, just five months after it was approved by the FDA.